MedTrace Logo

Investigating iLux Efficacy in Contact Lens Wearers With Evaporative Dry Eye Disease

NCT04159935 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2023-05-16

Study results available
· View outcomes & findings →

Summary

The purpose of this clinical trial is to investigate the efficacy of a single iLux® treatment in symptomatic CL wearers who have DED (according to the TFOS DEWS II diagnostic criteria), of the evaporative dry eye disease subtype (EDE).

Conditions

  • Dry Eye

Interventions

DEVICE

iLux® system

Commercially available medical device intended for use by qualified eye care professionals to apply localized heat and pressure therapy to a patient's eyelids.

Sponsors & Collaborators

  • Alcon Research

    collaborator INDUSTRY

  • University of Waterloo

    lead OTHER

Principal Investigators

  • Lyndon Jones, PhD, FCOptom · Centre for Ocular Research & Education

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-15
Primary Completion
2020-04-14
Completion
2020-04-14
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04159935 on ClinicalTrials.gov